Myeloid zinc finger 1 (MZF1) is a member of the SCAN domain family transcription factors that form dimers through their highly conserved SCAN motifs. Silencing of MZF1 inhibits cell proliferation, and abnormal expression of MZF1 results in cancer development. However, a potential role of MZF1 in metastasis remains unclear. Axl is a receptor tyrosine kinase and was first identified as a transforming gene in chronic myeloid leukemia. Axl overexpression induces proliferation, migration, and invasion and is highly expressed in different human cancers. In this study, we show that overexpression of MZF1 induces migration and invasion in colorectal (Rko, SW480) and cervical (HeLa) cancer cells. In addition, we show that MZF1 binds to the Axl promoter, transactivates promoter activity, and enhances Axl-mRNA and protein expression in a dose-dependent manner. In vitro, sh-RNA knockdown of Axl reduced MZF1-induced migration and invasion in HeLa and Rko cells (P = 0.05). Additionally, Rko cells overexpressing MZF1 showed increased tumor formation and liver metastasis in the chicken-embryo-metastasis assay in vivo. Furthermore, the expression of MZF1 and Axl was significantly higher in resected colorectal tumors compared with corresponding normal tissues (P = 0.02; P = 0.05), and MZF1 expression was positively correlated with Axl gene expression in tumor tissues (P < 0.01). Taken together, this is the first study to show that MZF1 induces invasion and in vivo metastasis in colorectal and cervical cancer, at least in part by regulating Axl gene expression. Mol Cancer Res; 8(2); 159-69. ©2010 AACR.
Introduction
The myeloid zinc finger gene-1, MZF1, encodes a transcription factor belonging to the krüppel family of zinc finger proteins. MZF1 contains 13 C2H2 zinc fingers arranged in two domains that are separated by a short glycine-and proline-rich sequence. Both of these DNA-binding domains (domain 1, zinc finger 1-4; domain 2, zinc finger 5-13) select similar DNA-binding consensus sequences, containing a core of four or five guanine residues: 1-4, 5′-AGTGGGGA-3′; 5-13, 5′-CGGGnGAGGGG-GAA-3′ (1) . Transcription of the gene leads to at least three transcripts of approximately 3, 7.5, and 9 kb. All three isoforms have two DNA-binding domains that interact with two different consensus sequences. Additionally, MZF1b and c encode a unique 257 amino acid amino terminus containing a SCAN box, or leucine-rich domain, which facilitates protein interactions (2) . Differential expression of MZF-1 interferes with hematopoietic cell differentiation and proliferation (3) (4) (5) and is associated with the antiapoptotic, oncogenic transformation of cell lines (6, 7) . MZF1 transcriptionally regulates protein kinase C α in human hepatocellular carcinoma (8) , which is an important family of signaling molecules that regulate cell proliferation, differentiation, transformation, and apoptosis. MZF1 antisense oligonucleotide-pretreated SK-Hep-1 human hepatocellular carcinoma cells showed reduced protein kinase C expression, and antisense-treated cells s.c. implanted into nude mice exhibited lower tumor growth and prolonged formation time (9) . However, an effect of MZF1 on invasion and metastasis, and associated target genes, have not yet been studied conclusively.
Axl receptor tyrosine kinase was originally described as a transforming gene isolated from chronic myeloid leukemia patients (10) . It belongs to the TAM (Tyro3, Axl, Mer) receptor tyrosine kinase family, sharing Gas6 as a common ligand, the product of growth arrest-specific gene 6 (11) . Gas6 binds to TAM family members with different affinities. Gas6 was first discovered as an upregulated gene in growth-arrested cells (12) , and further studies with Gas6 signaling suggested its role in cell survival (13, 14) , proliferation (15, 16) , stimulation of cell migration (17) , and cell-cell adhesion through Axl (18) . Intracellular signaling of Axl is also activated by its homophilic and heterophilic interactions (19) , mediated mainly by a multisubstrate docking site (20) . Overexpression of Axl can transform fibroblasts even in the absence of a ligand (21) , this is at least in part being mediated by Gas6/Axl-induced activation of mitogen-activated protein kinase/extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling. Following its identification in myeloid leukemia, Axl overexpression has been reported in several types of human solid cancers (22) (23) (24) (25) (26) (27) . Axl expression correlates with poor prognosis in acute myeloid leukemia (28) , gastric (29) , and advanced lung adenocarcinoma patients (27) , and with adhesion, motility, and invasiveness of osteosarcoma cells (30) . Transfection of dominant-negative Axl lacking the kinase domain into Axl-expressing glioblastoma cells reduces motility and the loss of cell-to-cell interaction (31) . Axl is required for normal migration of GnRH neurons from the olfactory placode to the hypothalamus (32) , and stable shRNA knockdown of Axl reduced blood vessel formation and functional circulation in a mouse model of angiogenesis (33) .
The Axl gene has a GC-rich promoter, lacking TATA and CAAT boxes and harboring multiple transcriptional start sites, these including the major one at −169, and a second major one at −460 bp upstream of the translation start site. Axl is constitutively regulated by Sp1/Sp3 transcription factors and further controlled by CpG island methylation within the Sp motifs and their flanking regions (34) . Interestingly, however, this GC-rich promoter additionally harbors multiple MZF1 binding motifs. Therefore, the aim of the present study was to investigate (a) if MZF1 is able to induce migration, invasion, and metastasis in vitro and in vivo in solid cancers; (b) if Axl gene expression is regulated by MZF1; (c) if MZF1-induced migration and invasion is mediated through Axl; and (d) if this is of biological relevance in resected patient tumors. The results here presented are the first to show that MZF1 induces migration, invasion, and Axl gene expression in colorectal and cervical cancer cells; that it induces tumor formation and liver metastasis in vivo; and that MZF1 and Axl are being coexpressed in colorectal cancer tissues.
Experimental Procedures

Cell Culture and Reagents
The human cervical cancer cell line HeLa and the colon cancer cell lines Rko and SW480 were purchased from the American Type Culture Collection and cultured in MEM Eagle, MEM, and L-15 medium, respectively, containing 10% heat-inactivated fetal bovine serum, at 37°C in an atmosphere of 5% CO 2 .
Cell Migration and Invasion Assay
HeLa, Rko, and SW480 cells were transfected either with mock or MZF1 expression vector. After 24 h, cells were trypsinized, and 3 × 10 5 cells were plated on Boyden chambers either coated with 10 μg Matrigel per well (for invasion assays) or uncoated (for in vitro migration assays) in serum-free medium containing 0.1% bovine serum albumin. Ten percent fetal bovine serum medium in the lower chamber served as chemoattractant. After 20 h, noninvading cells were removed with cotton swabs. Invaded cells were trypsinized and counted using the ATP-luminescence-based motility invasion assay (Promega) as previously described by Leupold JH et al. (35) .
RNA Isolation and Reverse Transcriptase-PCR
Total RNA was extracted by the RNeasy Midi kit (Qiagen) according to the manufacturer's instructions. Ten fresh frozen human colorectal tumor and corresponding normal tissues were obtained from the tumor banks of the department, which is approved by the institutional ethics committee. Tissues were homogenized and total RNA was isolated using Trizol (Invitrogen) according to the manufacturer's protocol. One microgram of total RNA (either from cells or tissues) was reversely transcribed by random hexamer primer using SuperScript II reverse transcriptase (Invitrogen). The single-strand cDNA was amplified by PCR using specific primer pairs with standard conditions. Glycer-aldehyde-3-phosphate dehydrogenase was used as an internal control. The PCR products were analyzed by electrophoresis on a 2% ethidium bromidestained agarose gel. The sequences of the sense (S) and antisense (AS) primers used for either semiquantitative, or Sybr green quantitative, PCR were as follows: MZF1 (S, 5′-AGTGTAAGCCCTCACCTCC-3′, and AS, 5′-GGGTCCTGTTCACTCCTCAG-3′), glycer-aldehyde-3-phosphate dehydrogenase (S, 5′-GTCTTCACCACCATG-GAGAA-3′, and AS, 5′-ATCCACAGTCTTCTGGGT-GG-3′), and Axl (S, 5′-GGTGGCTGTGAAGACGA-TGA-3′, and AS, 5′-CTCAGATACTCCATGCCACT-3′).
Preparation of Protein Extracts and Immunoblotting
Protein lysates were prepared as previously described by Mudduluru et al. (34) . Briefly, for immunoblotting, samples (40 μg/lane) were boiled for 5 min, separated through SDS-PAGE, and transferred to polyvinylidene difluoride membranes. After transfer, the membranes were blocked with 5% nonfat milk containing TBS with 0.1% Tween for 3 h at room temperature, and then probed with primary antibodies against either MZF1 (gift from Dr. Dorothy Tuan, the Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA; ref. 36) , Axl (#Santa cruz-1096), or Actin (#Santa cruz-1616-R) overnight at 4°C. After three washes with TBS with 0.1% Tween, blots were incubated with secondary antibodies conjugated with horseradish peroxidase. After final washes with TBS with 0.1% Tween, the membranes were exposed to film after enhanced chemiluminescence (Amersham Biosciences).
Generation of Luciferase Reporter Constructs and Expression Vectors
Luciferase reporter constructs were generated as described in Mudduluru et al. (34) . Expression vectors containing human MZF1 (37) were gifts from Dr. Tara Sander (Department of Surgery, Children's Research Institute Medical College of WI). Sh-RNA vectors of sh-Axl #RHS4430-98903492 (Mature Sense sequence: GATCC-TAAGCATCTAAGTT) and nonsilencing control (#RHS4346) were purchased from Open Biosystems.
Site-Directed Mutation Analysis
Mutant constructs were generated by the QuikChange XL site-directed mutagenesis kit from Stratagene using Axl1 (−1,276 to +7) as a template. Successful incorporation of the mutations was confirmed by automated sequencing.
Transfection and Dual-Luciferase Assays
For luciferase assays, 0.13 × 10 6 Rko or 0.05 × 10 6 HeLa cells were plated in 24 -well plates. Luciferase reporter plasmids (500 ng of each) with or without MZF1-expressing plasmids were transfected in regular medium using Effectine (Qiagen). For all luciferase reporter assays, pRL-TK (50 ng, Renilla Luciferase; Promega) was cotransfected and luminescence was measured to normalize transfection efficiency. Cells were washed twice with PBS and lysed with 100 μL passive lysis buffer (Promega) for 20 min. Twenty microliters of cell lysate were measured through the Dual-Luciferase reporter assay system (Promega) according to the manufacturer's instructions. Luciferase assays were performed after 24 h of transfection. Axl (−1,276 to +7) mock-treated luciferase activity was set to 100%, and activity of the other constructs was calculated and plotted as a percentage. Assays for all samples were done in triplicate, the error bars representing the SD.
Preparation of Nuclear Extracts and Electrophoretic Mobility Shift Assay
Preparation of nuclear extracts and electrophoretic mobility shift assays (EMSA) was done as previously described (34) . In brief, nuclear extracts (5 μg) were incubated in a buffer [25 mmol/L HEPES (pH 7.9), 0.5 mmol/L EDTA, 0.5 mmol/L DTT, 0.05 mol/L NaCl, and 4% (v/v) glycerol] with 50,000 cpm of the [ 33 P] ATP-end-labeled (phage T4 polynucleotide kinase, ICN #151935) oligonucleotide containing region −578/−538 of the Axl promoter for 20 min in the absence, or presence, of a 50-fold excess of wild-type, or 50-/100-fold excess of mutated, unlabeled oligonucleotides to show specificity of the binding at room temperature. A total of 0.5 μg of polydeoxyinosinic-deoxycytidylic acid was present in each reaction to block unspecific binding. The reactions were subjected to gel electrophoresis on a 5% polyacrylamide gel containing 5% glycerol in 0.25× Tris borate-EDTA buffer. For supershift analysis, 2 or 4 μg of MZF1 antibody were added to the reactions 20 min after nuclear extracts and oligonucleotide had been incubated. Supershift reactions were incubated for 60 min at 4°C and electrophoresed at 4°C to ensure complex stability. The gels were dried and analyzed by autoradiography.
Chorioallantoic Membrane Assay
The chorioallantoic membrane CAM assay was done as previously described (38, 39) . Tumors were weighed using electronic balance and the average of tumor weight was calculated among groups. Genomic DNA from embryonic livers was prepared using the Puregene DNA purification system. Quantification of human cells and DNA copy number, and Fluorogenic Taqman QPCR, was done as described by Leupold et al. (35) .
Statistical Analysis
Statistical analysis was done using the SPSS version 14.0 (SPSS). Student's t test was done to determine the statistically significant differences between groups. P values of ≤0.05 were considered significant.
Results
MZF1 Induces Migration and Invasion
To determine if MZF1 regulates migration and invasion in HeLa, Rko, and SW480, cells (showing low or no endogenous expression of MZF1, and no methylation of the Axl promoter; ref. 34) were either mock transfected with pCDNA3-vector or with pCDNA3-MZF1, respectively. After 24 h, cells were either studied in Boyden chambers for migration or in 10 μg Matrigel-coated chambers for invasion. MZF1-expressing cells showed significantly increased migration and invasion (P < 0.05) in three cells lines when compared with mock vector-expressing cells (Fig. 1A and B). Real-time PCR analysis was done, determining an overexpression of MZF1 ( Supplementary Fig. S1A-C) , and the results confirmed a significant overexpression in MZF1-transfected cells.
MZF1 Transactivates Axl Promoter Activity and Induces Axl Gene Expression
A TRANSFAC database search on the Axl promoter revealed that it harbors multiple putative MZF1 binding motifs ( Fig. 2A) . To determine the ability of MZF1 to regulate Axl promoter activity, MZF1 and a luciferase reporter driven by the −1,276/+7 upstream region of the Axl gene, which reflected maximum Axl promoter activity (34), were cotransfected into HeLa and Rko cells. The peptidyl arginine deiminase type I [PADI 1 (-195 to +84 bp)] promoter was transfected as a positive control (40) , which is regulated by MZF1 (Supplementary Fig. S2A ). MZF1 transactivated the Axl promoter in a dose-dependent manner in both of the cell lines (Fig. 2B) . To show that MZF1-induced Axl promoter activity results in an increase of Axl transcript and protein, HeLa cells were transfected with increasing concentrations of MZF1-expressing vector. After 48 hours, Axl mRNA and protein were found induced when compared with mock controls (Fig. 2C and  D) . Taken together, these data indicate that MZF1 transactivates the Axl promoter and positively regulates Axl gene expression.
MZF1 Binding Motifs Regulate Axl Promoter Activity
To analyze the functional relevance of the predicted putative MZF1 binding motifs for Axl promoter activity, three individual MZF1 binding motifs at −563/−557 bp, −479/−473 bp, −80/−72 bp, and combinations of all three of these motifs were mutated. The Sp1 binding motif reported previously (34) also harbors a putative MZF1 motif at −512/−504 bp; however, we have reported that this motif regulates promoter activity explicitly through the binding of Sp1 family members (34) . Hence, the particular motif was not included in this study. Mutation of all three of the MZF1 motifs tested reduced MZF1-inducible Axl promoter activity (Fig. 3A) . In particular, the MZF1 mutation at −479/−473 bp most significantly reduced constitutive, but especially MZF1-induced Axl promoter activity (Fig. 3A) , and other combined mutations did not further reduce either constitutive or MZF1-induced promoter activity compared with this mutation (data not shown; Fig. 3A) . These results suggest that the MZF1 binding motif at −479/−473 bp is the most important motif for Axl transactivation upon MZF1 overexpression.
MZF1 Nuclear Proteins Bind to the Axl Promoter
To show that the MZF1-induced Axl gene expression is dependent on its binding to the promoter, gel shift and supershift analysis were done using nuclear extracts either with mock or MZF1-transfected HeLa cells. EMSA analysis was done with oligonucleotides corresponding to the MZF1 binding motif at −563/−557 bp (100% consensus motif ) and the functionally most relevant −479/−473 bp (93% consensus) motif of the Axl promoter. To determine the specific binding of MZF1 to these motifs, a 50-fold excess of unlabeled wild-type, or a 50-and 100-fold excess of an oligo nucleotide mutated for the binding of MZF1, were used for cold competition. As shown in Fig. 3B , the competition with wild-type oligo nucleotides completely abolished the specific binding of transcription factors, whereas with the mutated oligos as competitors, the formation of specific complexes stayed intact. To show the specific binding of MZF1 to this motifs, a comparative supershift analysis with an MZF1-specific antibody was done with nuclear extracts of HeLa cells made to overexpress MZF1. Overexpression of MZF1 intensified the binding of especially one specific complex observed in the EMSA (Fig. 3C, down arrows) . With MZF1 antibody, a supershift of this specific band was seen (Fig. 3C, up arrows) . The MZF1 binding motif of the ERCC1 promoter (−324/−298 bp) was used as a positive control (41) , which showed a significant increase in MZF1 binding with MZF1-overexpressing nuclear extracts of HeLa cells (Supplementary Fig. S2B ). These results suggest that MZF1 
Axl Mediates MZF1-Induced Migration and Invasion
To show that Axl is one of the main mediators of MZF1-induced migration and invasion, sh-RNA expressing constructs targeting Axl, or nonsilencing constructs as controls, were cotransfected with the MZF1 expression construct into either HeLa or Rko cells. After 24 h, cells were either studied in Boyden chambers for migration or in Matrigel-coated chambers for invasion. As expected, MZF1-and nonsilencing vector-expressing cells showed induced migration (Fig. 4A) and invasion (Fig. 4B) in both of the cell lines when compared with mock-transfected cells. However, Axl-sh-RNA-and MZF1-expressing cells showed significantly less migration (Fig. 4A) and invasion (Fig. 4B ) when compared with MZF1-and nonsilencing vector-expressing cells; under similar conditions, they could not change cell proliferation significantly (data not shown). This was paralleled by the observation that MZF1 overexpression induced the expression of Axl protein in the both of the cell lines ( Fig. 4C and D) . In addition, Axl mRNA was induced by MZF1 in HeLa, Rko, and SW480 cells as expected (see supplementary Fig. S1 ). These results suggested that MZF1-induced migration and invasion is at least in part mediated through Axl.
MZF1 Enhances Tumor Formation and Metastasis
In vivo
Our previous results suggested that MZF1 induces migration and invasion in vitro. To study the effect of MZF1 overexpression on in vivo tumor formation and metastasis, we used the chicken-embryo-metastasis assay (CAM), which is able to differentiate primary tumor growth, intravasation, and metastasis in a highly sensitive and quantitative in vivo setting (35) . Rko cells transfected with pCDNA3-vector, or with pCDNA3-MZF1, were inoculated on the upper CAM of 10-day old chicken embryos, and chicken embryos were grown for 7 more days. On day 17, the in vivo primary tumors were resected from the upper CAM and were weighed. MZF1-transfected cells developed significantly higher tumor weights than vector-transfected cells in this model (P = 0.014; Fig. 5A ). At the same time, livers were harvested from the embryos, and the number of metastasized cells quantified with real-time Alu-PCR. Consequently, MZF1-transfected cells showed significantly higher metastasis than vector-transfected cells in the liver (Table 1 ; P = 0.05; Fig. 5C ). These two observations clearly implicate the ability of MZF1 to induce tumor formation and metastasis in vivo.
Axl Is Coexpressed with MZF1 in Resected Colorectal Tumors
Finally, to support the in vivo relevance of the mechanisms identified, 10 resected colorectal carcinoma tissues of patients and corresponding normal mucosae were FIGURE 3. MZF1 binds and transactivates the Axl promoter region. A, Axl (−1,276/+7), the promoter construct showing maximum activity, was mutated at diverse MZF1 binding motifs as indicated. One microgram of wild-type/mutant Axl promoter constructs along with Renilla luciferase plasmid were transfected into HeLa. Axl wild-type promoter activity was set to 100% (first bar), and activity of the mutated and/or MZF1 cotransfected constructs was plotted as a percentage of this value. The most significant reduction of constitutive and MZF1-induced activity was seen with the mutation at −479/−473 bp, compared with wild-type activity. All experiments were done in triplicate and the results were averaged and plotted as shown. Columns, mean; bars, SD; *, P < 0.05. B, EMSA was done with HeLa nuclear extract and a γ-p33-labeled oligonucleotide corresponding to the MZF1 binding motifs at −563/−557 bp and −479/−473 bp of the Axl promoter. For competition, a 50-fold excess of unlabeled wild-type or a 50-and 100-fold excess of mutant oligos preventing MZF1 binding was used. Bottom, the wild-type and a mutated oligonucleotide sequence. Specific MZF1 complexes are indicated with parenthesis. C, supershift analysis done for the same MZF1 binding motifs (−564/−558 bp and −479/−473 bp) with mock and MZF1-overexpressing HeLa nuclear extracts. Two and 4 μg of MZF1 antibody were used for supershift analysis; IgG served as negative control. Up arrows and parenthesis, specific supershifted complexes. Down arrows, the specific disappearance of the original band due to the antibody binding. Experiments were done thrice. Data represents one of the independent experiments. investigated for endogenous expression of MZF1 and Axl. We observed that 8 patients of 10 showed an increase of MZF1 gene expression in resected tumors compared with normal tissues (Fig. 6A ) and 7 patients of 10 also showed a higher Axl gene expression in tumors than normal tissues (Fig. 6B) . The differences between the mean Axl and MZF1 gene expression were significant (P = 0.05, P = 0.02) between resected tumor and corresponding normal tissue (Fig. 6C) . Furthermore, MZF1 gene expression was positively and significantly correlated with Axl gene expression in the resected tumor tissues (Rs = 0.87; P < 0.01; Fig. 6D ).
Discussion
This is the first comprehensive study to show that an overexpression of MZF1 transcription factor leads to the transactivation of Axl promoter activity and gene expression, resulting in an enhanced migratory, invasive, and in vivo metastatic potential of colorectal and cervical cancer cells. The in vivo relevance of this mechanism is supported by the observation that the expression of MZF1 and Axl is significantly increased in resected colorectal carcinomas compared with normal tissues, and that the observed expression of both correlates significantly in resected colorectal tumors. Our findings suggest that the induction of Axl, invasion, and metastasis by MZF1 is playing an important role in tumor formation and progression in solid cancers.
MZF1 was originally identified as one of the transcriptional regulators during hemopoietic development (42) . In later studies, it was found that overexpression of MZF1 inhibits apoptosis and promotes oncogenesis (6, 7) , and silencing of MZF1 with antisense oligonucleotides was shown to reduce tumor growth (9) . However, the mechanisms by which MZF1 exerts an oncogenic potential are unknown except that it can regulate protein kinase C α expression (8) . Moreover, data suggesting a tumorigenic potential of MZF1 have been controversial (43) . In the present study, we confirm that overexpression of MZF1 is tumorigenic, and for the first time, we report that MZF1 induces tumor growth and metastasis through the transactivation of Axl, thus adding to the molecular targets and mechanisms that can mediate an oncogenic potential of MZF1 in epithelialderived tissues. Axl has been reported as a transforming gene (21) that is overexpressed in several tumors (22) (23) (24) (25) (26) (27) , and the Gas6/Axl signaling pathway is known to induce cell proliferation, antiapoptosis, migration, invasion, and angiogenic processes, which are most likely mediated through Ras, Src, mitogen-activated protein kinase/extracellular signal-regulated kinase, phosphoinositide 3-kinase/Akt, and NF-κB signaling pathways (14, 15, 19, 29, 31, 32, (44) (45) (46) (47) (48) (49) . However, still further studies are needed to enhance the understanding of the downstream components of the Gas6/Axl signaling axis in tumor formation. It is known that an overexpression of the Axl gene can lead to the activation of Axl by autophosphorylation (50), this in turn being able to activate the Axl signaling axis. This is the most likely mechanism to explain our observation that upon MZF1 stimulation, Axl is significantly overexpressed, this enhancing migration and invasion. For the latter, the presence of Axl has been shown to be essential in our present study because an sh-RNA knockdown strategy on Axl reduced MZF1-inducible migration and invasion considerably. The in vivo relevance of MZF1-induced Axl overexpression, this hypothetically leading to Axl autoactivation and activation of the Axl signaling axis, is supported by the observation that MZF1 is able to induce tumor growth and metastasis in the CAM in vivo model, and especially also by the observation in resected patient tissues that primary colorectal cancers express significantly higher amounts of endogenous MZF1 than corresponding normal tissues, this being significantly associated with a parallel increase of endogenous Axl gene expression. MZF1 has been initially described as a transcription factor important for the development of cells of the hemopoietic origin. In addition, correspondingly, many hemopoietic cell-specific genes such as CD34, lactoferrin, and myeloperoxidase are regulated by MZF1 (4, 51, 52), whereas very few genes of cell types of different origin (e.g., keratinocytes, osteoblasts) such as PADI 1 and N-cadherin are transactived by MZF1 (40, 53) . Axl is expressed in certain leukemia-type cells, but also in diverse solid tumors (22) (23) (24) (25) (26) (27) , and excitingly, we found that the Axl gene promoter harbors multiple MZF1 motifs. Among them, mutation of the MZF1 motif at −479/ −473 bp reduced promoter activity most significantly, and additional combination mutations did not show considerably more reduction of activity, showing that this motif is the most relevant for Axl transactivation by MZF1. Furthermore, promoter analysis indicated that the upstream region between −1,276 to +7 of the Axl gene, which we have characterized previously as the maximum Axl promoter (34) , containing all putative MZF1 binding motifs, showed induced promoter activity upon MZF1 overexpression in cultured colorectal and cervical cancer. Deletion of MZF1 binding consensus were inoculated on the upper CAM of chicken eggs (n = 10). The tumor weights were measured and DNAs of the livers were extracted 7 d after inoculation. A, average of tumor weights from MZF1-transfected compared with mock vector-transfected cells. B, two tumors from two independent eggs from each group (mock-and MZF1-transfected samples) are represented. The scale is indicated in centimeters. C, the genomic DNA was analyzed by Real-time Alu-PCR to determine the number of metastasized Rko cells in livers. The individual cell number per egg is given in the adjacent box. The CAM assay was done twice with independent transfections. Columns, mean of two independent experiments; bars, SD. **, P < 0.014; *, P = 0.05. sequences in the −1,276 to +7 Axl promoter luciferase construct did not show a significant reduction of spontaneous constitutive promoter activity, which is not surprising because we have already shown that constitutive Axl gene expression is regulated by GC-rich zinc finger binding transcription factors Sp1/Sp3 (34) . Therefore, from the present study, it can be concluded that overexpressed MZF1 binds to the Axl promoter, inducing Axl promoter activity and gene expression.
Taken together, this is the first comprehensive analysis of the ability of MZF1 to induce migration, invasion, tumor formation, and metastasis in vivo in cultured colorectal and cervical cancer. Our results suggest that MZF1 plays an important role in inducing these phenomena through the transactivation of Axl in solid tumors. Therefore, further studies aiming at a better understanding of the pathways that lead to an induced MZF1/Axl gene expression in solid tumors and also the screening of a larger series of patients are clearly warranted.
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